S. Pechtel

Absence of the JAK2 mutation V617F in CD34+ hematopoietic stem and progenitor cells from patients with BCR-ABL-positive CML in chronic phase and blast crisis.

U. Steidl, R. Haas, R. Kronenwett, 2006, Leukemia research.

Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor

A. von Haeseler, D. Tenen, P. Wernet, 2008, Haematologica.

Prognostic impact of pretransplant measurable residual disease assessed by peripheral blood WT1‐mRNA expression in patients with AML and MDS

U. Germing, G. Kobbe, J. Kaivers, 2021, European journal of haematology.

Molecular signature of CD34+ hematopoietic stem and progenitor cells of patients with CML in chronic phase

B. Brors, A. Haeseler, I. Bruns, 2007, Leukemia.

Distinct Gene Expression Pattern of Malignant Hematopoietic Stem and Progenitor Cells in Polycythemia Vera

C. Steidl, U. Steidl, G. Kobbe, 2005, Annals of the New York Academy of Sciences.

Wilms' Tumor 1 Gene Expression Using a Standardized European LeukemiaNet-Certified Assay Compared to Other Methods for Detection of Minimal Residual Disease in Myelodysplastic Syndrome and Acute Myelogenous Leukemia after Allogeneic Blood Stem Cell Transplantation.

D. Wieczorek, U. Germing, G. Kobbe, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prediction of Response and Survival Following Treatment with Azacitidine for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation

U. Germing, G. Kobbe, J. Kaivers, 2020, Cancers.

Wilm’s Tumor 1-guided preemptive treatment with hypomethylating agents for molecular relapse of AML and MDS after allogeneic transplantation

U. Germing, G. Kobbe, R. Haas, 2020, Bone Marrow Transplantation.

Prognostic value of circulating Bcl-2/IgH levels in patients with follicular lymphoma receiving first-line immunochemotherapy.

I. Bruns, W. Brugger, N. Niederle, 2015, Blood.

Prognostic impact of peripheral blood WT1-mRNA expression in patients with MDS

U. Germing, G. Kobbe, R. Haas, 2019, Blood Cancer Journal.

Pegylated G-CSF Mobilizes CD34+ Cells with Different Stem and Progenitor Cell Subsets and Distinct Functional Properties in Comparison with Unconjugated G-CSF.

D. Tenen, P. Wernet, A. Haeseler, 2006 .